Lead Product(s) : CDR202
Therapeutic Area : Ophthalmology
Study Phase : Preclinical
Sponsor : Boehringer Ingelheim GmbH
Deal Size : $487.7 million
Deal Type : Collaboration
Details : Under the collaboration, the partners will advance CDR-Life’s preclinical antibody fragment-based therapeutic including CDR202, targeting a key pathway in geographic atrophy (GA).
Product Name : CDR202
Product Type : Other Large Molecule
Upfront Cash : Undisclosed
February 08, 2023
Lead Product(s) : CDR202
Therapeutic Area : Ophthalmology
Highest Development Status : Preclinical
Sponsor : Boehringer Ingelheim GmbH
Deal Size : $487.7 million
Deal Type : Collaboration
Lead Product(s) : Undisclosed
Therapeutic Area : Ophthalmology
Study Phase : Preclinical
Sponsor : Novartis Pharmaceuticals Corporation
Deal Size : Undisclosed
Deal Type : Acquisition
Details : The acquisition underscores the Novartis commitment to finding treatments for patients with vision loss and the potential of Optogenetics-based AAV gene therapy as the basis of successful therapeutics.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
September 21, 2021
Lead Product(s) : Undisclosed
Therapeutic Area : Ophthalmology
Highest Development Status : Preclinical
Sponsor : Novartis Pharmaceuticals Corporation
Deal Size : Undisclosed
Deal Type : Acquisition
Lead Product(s) : Undisclosed
Therapeutic Area : Ophthalmology
Study Phase : Preclinical
Sponsor : Boehringer Ingelheim GmbH
Deal Size : $494.0 million
Deal Type : Licensing Agreement
Details : Together, with Boehringer Ingelheim’s expertise in the therapeutic development of biologics and CDR-Life’s strong know-how in antibody engineering, the two companies will progress CDR-Life’s preclinical candidate, with the aim to preserve sight for...
Product Name : Undisclosed
Product Type : Antibody
Upfront Cash : Undisclosed
May 13, 2020
Lead Product(s) : Undisclosed
Therapeutic Area : Ophthalmology
Highest Development Status : Preclinical
Sponsor : Boehringer Ingelheim GmbH
Deal Size : $494.0 million
Deal Type : Licensing Agreement